Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant

Int J Nanomedicine. 2013:8:1843-54. doi: 10.2147/IJN.S43827. Epub 2013 May 9.

Abstract

Background: The heterologous deoxyribonucleic acid (DNA) prime-adenovirus (AdV) boost vaccination approach has been widely applied as a promising strategy against human immunodeficiency virus (HIV)-1. However, the problem of inefficient delivery and lack of specificity of DNA vaccine remains a major issue. In this paper, to improve the transfection of DNA vaccine and realize dendritic cell targeting, we used mannosylated polyethyleneimine (man-PEI) as a DNA vector carrier.

Method: The DNA plasmid encoding antigen HIV gag fragment was constructed by polymerase chain reaction. Then the DNA plasmid was complexed with man-PEI. The in vitro transfection efficiency of man-PEI/DNA was analyzed on DC 2.4 cells. Mice were primed with 25 μg pVAX1-HIV gag plasmid complexed with man-PEI, 100 μg naked pVAX1-HIV gag plasmid, or empty pVAX1 vector and boosted by AdV encoding the same antigen. The antibody titer, CD4(+) and CD8(+) T-cell response, as well as interferon-γ and interleukin-4 levels in serum and in splenocytes culture were analyzed using flow cytometry or enzyme-linked immunosorbent assay to evaluate the immune response. To test a long-term effect of the vaccination regimen, CD8(+) memory T-cell was also detected by flow cytometry.

Results: The pVAX1-HIV gag was constructed successfully. The in vitro transfection efficiency in dendritic cells was significantly higher than naked DNA plasmid. Compared with 100 μg naked DNA/AdV group, the immunoglobulin G2a antibody titer, T-cell response percentage, and cytokine production level induced by man-PEI/DNA/AdV group were significantly higher at a lower DNA dose. Also, the man-PEI/DNA could stimulate a memory CD8(+) T-cell response.

Conclusion: Owing to the adjuvant effect of man-PEI, the man-PEI/pVAX1-HIV gag priming plus AdV boosting strategy proved to be a potent vaccine candidate against HIV, which could induce a stronger immune response with a lower DNA dose.

Keywords: DNA delivery; heterologous vaccination; human immunodeficiency virus; immune response; mannosylated polyethyleneimine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines / chemistry
  • AIDS Vaccines / genetics
  • AIDS Vaccines / immunology*
  • Adenoviridae / genetics
  • Adjuvants, Immunologic / chemistry*
  • Animals
  • Antibodies, Viral / blood
  • Female
  • HIV-1 / immunology*
  • Interferon-gamma / analysis
  • Interferon-gamma / metabolism
  • Interleukin-4 / analysis
  • Interleukin-4 / metabolism
  • Mannose / chemistry
  • Mice
  • Mice, Inbred BALB C
  • Polyethyleneimine / chemistry
  • T-Lymphocytes / immunology
  • Transfection / methods*
  • Vaccines, DNA / chemistry
  • Vaccines, DNA / genetics
  • Vaccines, DNA / immunology*
  • gag Gene Products, Human Immunodeficiency Virus / genetics
  • gag Gene Products, Human Immunodeficiency Virus / immunology

Substances

  • AIDS Vaccines
  • Adjuvants, Immunologic
  • Antibodies, Viral
  • Vaccines, DNA
  • gag Gene Products, Human Immunodeficiency Virus
  • Interleukin-4
  • Interferon-gamma
  • Polyethyleneimine
  • Mannose